If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

Dr. Shouhao Zhou's research focuses on the development of statistical methods for Bayesian model selection, meta-analysis, biomarker dynamic prediction, clinical trial and experimental design and estimation of drug synergism in combination studies, with applications in leukemia, lymphoma, glioma, imaging and medical physics, among many others.

Dr. Zhou served as co-leader of biostatistics core at Lymphoma SPORE, lead statistician/co-investigator of GBM and B-cell lymphoma moonshot programs at M.D. Anderson Cancer Center, and has held various NIH grants. He has been a statistical consultant and collaborator for academic research in medical sciences for many years and is enthusiastic to develop tailored solutions for both pre-clinical and clinical research that would have significant real-life implications.

Education/Academic qualification

PhD, Columbia University

… → 2011

Fingerprint Dive into the research topics where Shouhao Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Glioblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neuroendocrine Tumors Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Glioma Medicine & Life Sciences
Survival Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

1 Citation (Scopus)

Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma

Guo, H., Zeng, D., Zhang, H., Bell, T., Yao, J., Liu, Y., Huang, S., Li, C. J., Lorence, E., Zhou, S., Gong, T., Jiang, C., Ahmed, M., Yao, Y., Nomie, K. J., Zhang, L. & Wang, M., Mar 14 2019, In : Oncogene. 38, 11, p. 1802-1814 13 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Phosphatidylinositol 3-Kinases
Histones
Acetylation
CUDC-907

Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin

Liu, W., Qdaisat, A., Soliman, P. T., Ramondetta, L., Lopez, G., Narayanan, S., Zhou, S., Cohen, L., Bruera, E. & Yeung, S. C. J., Jun 1 2019, In : Oncologist. 24, 6, p. e312-e317

Research output: Contribution to journalArticle

Carboplatin
Ovarian Neoplasms
Drug Therapy
Survival
Magnesium
2 Citations (Scopus)

Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma

Zhang, L., Yao, Y., Zhang, S., Liu, Y., Guo, H., Ahmed, M., Bell, T., Zhang, H., Han, G., Lorence, E., Badillo, M., Zhou, S., Sun, Y., Di Francesco, M. E., Feng, N., Haun, R., Lan, R., MacKintosh, S. G., Mao, X., Song, X. & 11 others, Zhang, J., Pham, L. V., Lorenzi, P. L., Marszalek, J., Heffernan, T., Draetta, G., Jones, P., Futreal, A., Nomie, K., Wang, L. & Wang, M., Jan 1 2019, In : Science Translational Medicine. 11, 491, eaau1167.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Oxidative Phosphorylation
Neoplasms
Metabolic Networks and Pathways
Electron Transport Complex I
4 Citations (Scopus)

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

Wei, J., Marisetty, A., Schrand, B., Gabrusiewicz, K., Hashimoto, Y., Ott, M., Grami, Z., Kong, L. Y., Ling, X., Caruso, H., Zhou, S., Wang, Y. A., Fuller, G. N., Huse, J., Gilboa, E., Kang, N., Huang, X., Verhaak, R., Li, S. & Heimberger, A. B., Jan 2 2019, In : Journal of Clinical Investigation. 129, 1, CI121266.

Research output: Contribution to journalArticle

Osteopontin
Glioblastoma
Macrophages
Glioma
Therapeutics

The Association Between Common Clinical Characteristics and Postoperative Morbidity and Overall Survival in Patients with Glioblastoma

Liu, W., Qdaisat, A., Yeung, J., Lopez, G., Weinberg, J., Zhou, S., Cohen, L., Bruera, E. & Yeung, S. C. J., Apr 1 2019, In : Oncologist. 24, 4, p. 529-536 8 p.

Research output: Contribution to journalArticle

Glioblastoma
Blood Pressure
Morbidity
Survival
Odds Ratio